Hepatology Associates Course, Part 1: Hepatology Associates as Leaders in Multidisciplinary Care
Nov
09
2025
Convention Center: Room 146B, Level 1
8:00 AM - 9:30 AM
World Class Speakers
Description
The Associates Course expands the knowledge base of participants to improve patient outcomes in behavioral, nutritional, and pharmacologic interventions in chronic liver disease. Speakers explore topics including: (1) novel treatment models of chronic hepatitis C and MASLD/MASH; (2) pharmacist driven management of chronic liver disease; (3) resource-limited management of chronic liver disease; and (4) palliative approaches to management of patients with chronic liver disease.Journey Maps
Presentations
8:00 AM - 8:20 AM
Nov
09
2025
Washington, D.C.
Facilitating Behavioral Modification in Metabolic Dysfunction-Associated Steatotic Liver Disease
Lisa L Catalli, MSN, NP-BC, Presenter
Hepatology Associates
8:20 AM - 8:40 AM
Nov
09
2025
Washington, D.C.
The Impact of Nutrition Across the Spectrum of Chronic Liver Disease
Whitney Steinmetz, FNP, Presenter
Hepatology Associates
8:40 AM - 9:00 AM
Nov
09
2025
Washington, D.C.
Fostering Community-Centered Metabolic Dysfunction-Associated Steatotic Liver Disease Care
Anna Hefner, PhD, FAASLD, Presenter
Hepatology Associates
9:00 AM - 9:20 AM
Nov
09
2025
Washington, D.C.
Integrating Palliative Care Into Hepatology Practice
Susan A Zapatka, MSN, APRN, ANC-BC, Presenter
Hepatology Associates
Objectives
- Review evidence-based approaches to supporting behavior change and improving outcomes in MASLD/MASH.
- Describe a novel community-centered treatment model for patients with MASLD/MASH.
- Discuss the role of dietetics in optimizing outcomes across the spectrum of chronic liver disease.
- Appraise palliative models of care for patients with advanced liver disease.
Chair
Scott Springer, PA-C, MPAS
Erie County Medical Center
Chair
Elizabeth Stonesifer, MD
Penn State Milton S. Hershey Medical Center